M&A Deal Summary

GIMV Acquires SMG Sportplatzmaschinenbau

On June 7, 2024, private equity firm GIMV acquired machinery company SMG Sportplatzmaschinenbau

Acquisition Highlights
  • This is GIMV’s 6th transaction in the Machinery sector.
  • This is GIMV’s 20th transaction in Germany.

M&A Deal Summary
Date 2024-06-07
Target SMG Sportplatzmaschinenbau
Sector Machinery
Buyer(s) GIMV
Deal Type Buyout (LBO, MBO, MBI)

Target

SMG Sportplatzmaschinenbau

Vohringen, Germany
SMG Sportplatzmaschinenbau is developing modern machines for laying synthetic flooring in the sports sector. SMG has also been introducing world firsts for the maintenance of artificial turf or carpets with granulate infill since the 1980s. For almost half a century, SMG has offered a unique range of machines. SMG Sportplatzmaschinenbau was founded in 1975 and is based in Vohringen, Germany.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.

DEAL STATS #
Overall 158 of 158
Sector (Machinery) 6 of 6
Type (Buyout (LBO, MBO, MBI)) 52 of 52
Country (Germany) 20 of 20
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-22 SynOx Therapeutics

Dublin, Ireland

SynOx Therapeutics develops Emactuzumab a potential best-in-class clinical-stage CSF-1R targeted antibody designed to target and deplete macrophages in the tumour tissue. It has shown a favourable safety profile and encouraging efficacy in patients with diffuse tenosynovial giant cell tumours (dTGCT), a rare oncology disease. SynOx Therapeutics was founded in 2020 and is based in Dublin, Ireland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-24 JenaValve Technology

Irvine, California, United States

JenaValve Technology specializes in developing transcatheter aortic valves that can be implanted via the femoral vein or an incision between two ribs. JenaValve Technology was founded in 2006 and is based in Irvine, California.

Sell -
Mergr

Product

Company

Legal